Articles related to ovarian cancer chemotherapy; GOG 252; UAB clinical trial for ovarian cancer; pac


Ovarian Cancer Patients Do Not Benefit from Dose-Dense Chemotherapy
Ovarian Cancer Patients Do Not Benefit from Dose-Dense Chemotherapy
Ovarian cancer is responsible for about 14,000 deaths in the United States every year. A better understanding of treatments for this lethal cancer is leading researchers to further investigate the outcomes of some studies that may be raising as many questions as answers.
Read More
https://uniti.ua

steroid-pharm.com/

https://granit-sunrise.com.ua
Powered by

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: